針葉の代謝物であるピシフェル酸は,病原性配列変異を有するヒトKv1.2のカリウムチャネルにおける活性を再生する

Rían W Manville¹, Richard Sidlow², Geoffrey W Abbott¹

¹Bioelectricity Laboratory, Department of Physiology and Biophysics, School of Medicine, University of California, Irvine, Irvine, CA, USA.

iScience

|September 2, 2025

まとめ

ピシフェリック酸 (PA) は,KCNA2遺伝子障害の治療に有望である. この化合物は,Kv1.2チャンネル変異の機能喪失で効果的に機能を回復し,潜在的な治療用途を示唆しました.

科学分野:

神経科学
遺伝学
薬理学について

背景:

Kv1.2 カリウムチャネルをコードするKCNA2遺伝子の配列変異は,,認知遅延,運動障害に関連しています.
機能不全のKv1.2チャネルは,痛みとアミオトロフィック横筋硬化症 (ALS) にも関係しています.
現在,突然変異したKv1.2の機能を直接修正する治療法は限られている.

研究の目的:

人間のKv1.2遺伝子変異を分類し,ピシフェリック酸 (PA) の治療の可能性を評価する.
Kv1.2チャネル機能に対するPAの作用機構を調査する.
KCNA2関連疾患における鉛化合物としてのPAを評価する.

主な方法:

細胞電気生理学を用いて,ヒトのKv1. 2変種 (病原性または重要性は不明) を機能喪失 (LOF),機能獲得 (GOF),または混合LOF/GOFに分類した.
シリコドッキングでは,変異と電気生理学がPA結合部位を特定した.
PAのインビトロ有効性と臨床前毒性は評価された.

主要な成果:

13/13 LOFと1/1 LOF/GOFの病原性Kv1.2変種で,活性化の電圧依存をハイパーポラライズすることで,機能が改善されました.
Kv1.2の電圧センサー内のPAの特定の結合部位が特定されました.
PAは低臨床前毒性を示した.

結論:

ピシフェリック酸はKv1.2機能障害の治療に有望な鉛化合物である.
や他の神経疾患の治療戦略として利用できる.
KCNA2関連疾患の新たな治療法につながる可能性がある.

キーワード:

バイオ物理学細胞生物学分子生物学分子薬理学について

さらに関連する動画

08:11

Voltage-Dependent Potassium Current Recording on H9c2 Cardiomyocytes via the Whole-Cell Patch-Clamp Technique

Published on: November 11, 2022

3.0K

15:28

Mutagenesis and Functional Analysis of Ion Channels Heterologously Expressed in Mammalian Cells

Published on: October 1, 2010

17.5K

関連する概念動画

01:20

Antiepileptic Drugs: Potassium Channel Activators

274

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...

274

01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

1.2K

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...

1.2K

01:24

Non-gated Ion Channels

7.1K

Ion channels are specialized proteins on the plasma membrane that allow charged ions to pass down their electrochemical gradient. Their main function is to maintain the membrane potential which is critical for cell viability. These channels are either gated or non-gated and can transport more than a thousand ions within milliseconds for the cellular event to occur.
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism....

7.1K

01:26

Voltage-gated Ion Channels

8.6K

Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several...

8.6K

01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

2.6K

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...